ReGenX Biosciences Pipeline
| Drug | Indication | Phase |
|---|
| RGX-121 | Mucopolysaccharidosis Type II (MPS II, Hunter syndrome) | Phase 2/3 |
| RGX-314 | Wet Age-Related Macular Degeneration (AMD) | Phase 2/3 |
| RGX-202 | Duchenne Muscular Dystrophy (DMD) | Phase 1/2 |
| RGX-381 | Ocular Manifestations of Fabry Disease | Preclinical |